These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Competing-risks model in screening for pre-eclampsia by maternal factors and biomarkers at 35-37 weeks' gestation. Andrietti S; Silva M; Wright A; Wright D; Nicolaides KH Ultrasound Obstet Gynecol; 2016 Jul; 48(1):72-9. PubMed ID: 26566592 [TBL] [Abstract][Full Text] [Related]
4. Comparison of screening for pre-eclampsia at 31-34 weeks' gestation by sFlt-1/PlGF ratio and a method combining maternal factors with sFlt-1 and PlGF. Tan MY; Wright D; Koutoulas L; Akolekar R; Nicolaides KH Ultrasound Obstet Gynecol; 2017 Feb; 49(2):201-208. PubMed ID: 27671370 [TBL] [Abstract][Full Text] [Related]
5. Longitudinal changes in maternal serum placental growth factor and soluble fms-like tyrosine kinase-1 in women at increased risk of pre-eclampsia. Khalil A; Maiz N; Garcia-Mandujano R; Penco JM; Nicolaides KH Ultrasound Obstet Gynecol; 2016 Mar; 47(3):324-31. PubMed ID: 26387758 [TBL] [Abstract][Full Text] [Related]
6. Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 30-34 weeks' gestation. Tsiakkas A; Saiid Y; Wright A; Wright D; Nicolaides KH Am J Obstet Gynecol; 2016 Jul; 215(1):87.e1-87.e17. PubMed ID: 26875953 [TBL] [Abstract][Full Text] [Related]
7. Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 19-24 weeks' gestation. Gallo DM; Wright D; Casanova C; Campanero M; Nicolaides KH Am J Obstet Gynecol; 2016 May; 214(5):619.e1-619.e17. PubMed ID: 26627730 [TBL] [Abstract][Full Text] [Related]
8. Development of pre-eclampsia within 4 weeks of sFlt-1/PlGF ratio > 38: comparison of performance at 31-34 vs 35-37 weeks' gestation. Dragan I; Wright D; Fiolna M; Leipold G; Nicolaides KH Ultrasound Obstet Gynecol; 2017 Feb; 49(2):209-212. PubMed ID: 27671743 [TBL] [Abstract][Full Text] [Related]
15. Predictive value of angiogenic factors, clinical risk factors and uterine artery Doppler for pre-eclampsia and fetal growth restriction in second and third trimester pregnancies in an Ecuadorian population. Kienast C; Moya W; Rodriguez O; Jijón A; Geipel A J Matern Fetal Neonatal Med; 2016; 29(4):537-43. PubMed ID: 25708492 [TBL] [Abstract][Full Text] [Related]
16. Repeat measurements of uterine artery pulsatility index, mean arterial pressure and serum placental growth factor at 12, 22 and 32 weeks in prediction of pre-eclampsia. Andrietti S; Carlucci S; Wright A; Wright D; Nicolaides KH Ultrasound Obstet Gynecol; 2017 Aug; 50(2):221-227. PubMed ID: 28078815 [TBL] [Abstract][Full Text] [Related]
17. Prediction of small-for-gestational-age neonates: screening by biophysical and biochemical markers at 30-34 weeks. Bakalis S; Peeva G; Gonzalez R; Poon LC; Nicolaides KH Ultrasound Obstet Gynecol; 2015 Oct; 46(4):446-51. PubMed ID: 25826154 [TBL] [Abstract][Full Text] [Related]
18. Serum soluble fms-like tyrosine kinase-1 in the three trimesters of pregnancy: effects of maternal characteristics and medical history. Tsiakkas A; Duvdevani N; Wright A; Wright D; Nicolaides KH Ultrasound Obstet Gynecol; 2015 May; 45(5):584-90. PubMed ID: 25678265 [TBL] [Abstract][Full Text] [Related]